Additionally, the 36-month beta value for ALLK is 0.56. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”
The public float for ALLK is 75.74M and currently, short sellers hold a 2.56% ratio of that float. The average trading volume of ALLK on March 19, 2025 was 2.40M shares.
ALLK) stock’s latest price update
The stock price of Allakos Inc (NASDAQ: ALLK) has plunged by -0.02 when compared to previous closing price of 0.26, but the company has seen a -1.90% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-03-12 that SAN CARLOS, Calif., March 12, 2025 (GLOBE NEWSWIRE) — Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company that has been developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for the fourth quarter ended December 31, 2024.
ALLK’s Market Performance
ALLK’s stock has fallen by -1.90% in the past week, with a monthly drop of -17.77% and a quarterly drop of -75.70%. The volatility ratio for the week is 4.76% while the volatility levels for the last 30 days are 6.77% for Allakos Inc The simple moving average for the past 20 days is -4.03% for ALLK’s stock, with a -68.52% simple moving average for the past 200 days.
Analysts’ Opinion of ALLK
Many brokerage firms have already submitted their reports for ALLK stocks, with Jefferies repeating the rating for ALLK by listing it as a “Hold.” The predicted price for ALLK in the upcoming period, according to Jefferies is $1.50 based on the research report published on January 17, 2024 of the previous year 2024.
ALLK Trading at -44.02% from the 50-Day Moving Average
After a stumble in the market that brought ALLK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.59% of loss for the given period.
Volatility was left at 6.77%, however, over the last 30 days, the volatility rate increased by 4.76%, as shares sank -12.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -78.00% lower at present.
During the last 5 trading sessions, ALLK fell by -1.88%, which changed the moving average for the period of 200-days by -78.91% in comparison to the 20-day moving average, which settled at $0.2659. In addition, Allakos Inc saw -78.91% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ALLK starting from Alexander Robert, who proposed sale 31,370 shares at the price of $0.26 back on Mar 06 ’25. After this action, Alexander Robert now owns shares of Allakos Inc, valued at $8,021 using the latest closing price.
Tomasi Adam, the Officer of Allakos Inc, proposed sale 20,017 shares at $0.26 during a trade that took place back on Mar 05 ’25, which means that Tomasi Adam is holding shares at $5,212 based on the most recent closing price.
Stock Fundamentals for ALLK
The total capital return value is set at -1.2. Equity return is now at value -121.68, with -87.64 for asset returns.
Based on Allakos Inc (ALLK), the company’s capital structure generated 0.05 points at debt to capital in total, while cash flow to debt ratio is standing at -22.52.
Currently, EBITDA for the company is -122.22 million with net debt to EBITDA at 0.12. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.08.
Conclusion
In conclusion, Allakos Inc (ALLK) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
